Skip to main content
. 2023 May 12:1–19. Online ahead of print. doi: 10.1038/s41573-023-00692-8

Fig. 3. The pharmacokinetic profile of a hypothetical antiviral compound administered twice daily.

Fig. 3

The free (unbound) drug plasma concentration (blue) is depicted, including the maximum drug concentration (Cmax) and minimum drug concentration (Cmin) at steady state. The 90% effective concentration (EC90; red dotted line), the concentration at which 90% inhibition of viral replication is observed in cellular antiviral assays, is corrected for plasma protein binding. BID, twice daily.